Wenjian Lan Selected Research

hirsutanol A

7/2021

Hirsutanol A inhibits T-acute lymphocytic leukemia Jurkat cell viability through cell cycle arrest and p53-dependent induction of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenjian Lan Research Topics

Disease

4	Neoplasms (Cancer) 07/2021 - 08/2015
2	Colorectal Neoplasms (Colorectal Cancer) 03/2018 - 10/2015
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 07/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2021
1	Triple Negative Breast Neoplasms 05/2021
1	Glioma (Gliomas) 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2015
1	Colonic Neoplasms (Colon Cancer) 08/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2015

Drug/Important Bio-Agent (IBA)

2	GliotoxinIBA 03/2018 - 10/2015
1	hirsutanol AIBA 07/2021
1	pifithrinIBA 07/2021
1	Nonprescription Drugs (Patent Medicines)IBA 05/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	alpha-hydroxyglutarateIBA 01/2021
1	LuciferasesIBA 10/2015
1	CateninsIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 08/2015
1	methyl sartortuoateIBA 08/2015
1	Terpenes (Terpenoids)IBA 08/2015
1	Caspase 3 (Caspase-3)IBA 08/2015
1	Caspase 8 (Caspase-8)IBA 08/2015
1	Caspase 9IBA 08/2015

Therapy/Procedure

1	Therapeutics 05/2021